Another study analysed MG132, epoxomicin, and proteasome inhibitors I and BAY 11-7082 as antitumour providers in thyroid malignancy cells
Another study analysed MG132, epoxomicin, and proteasome inhibitors I and BAY 11-7082 as antitumour providers in thyroid malignancy cells. lines.…